IndraLab

Statements


| 4

reach
"In addition, we explored the underlying mechanisms of the combined therapy, and showed that usp9x inhibition by WP1130 promoted the degradation of p53 in doxorubicin-treated HCC cells.Human liver canc[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"WP1130 also increases sensitivity to doxorubicin via degrading p53 by a USP9X dependent mechanism in HCC cells XREF_BIBR."

reach
"Our previous study found that, as a potential downstream gene of miR-212, USP9X promote doxorubicin resistance in HCC [ 24 ]."

reach
"Results showed that downregulation of usp9x enhanced the doxorubicin cytotoxicity in Huh7, HepG2, and SNU387 cells except for Hep3B cells ( Fig. 4E–H )."